List of Excipients in API esomeprazole magneisum d/r
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing esomeprazole magneisum d/r
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 | ALCOHOL |
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 | AMMONIA |
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 | BEET |
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 | BUTYL ALCOHOL |
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 | FD&C BLUE NO. 1 |
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 | FD&C RED NO. 40 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for esomeprazole magneisum d/r
Excipient focus: ALCOHOL
esomeprazole magneisum d/r drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
esomeprazole magneisum d/r drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BEET
esomeprazole magneisum d/r drug variants containing BEET
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing BEET
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
esomeprazole magneisum d/r drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
esomeprazole magneisum d/r drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
esomeprazole magneisum d/r drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
esomeprazole magneisum d/r drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
esomeprazole magneisum d/r drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
esomeprazole magneisum d/r drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
esomeprazole magneisum d/r drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
esomeprazole magneisum d/r drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
esomeprazole magneisum d/r drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEGLUMINE
esomeprazole magneisum d/r drug variants containing MEGLUMINE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing MEGLUMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
esomeprazole magneisum d/r drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
esomeprazole magneisum d/r drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLENE CHLORIDE
esomeprazole magneisum d/r drug variants containing METHYLENE CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing METHYLENE CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
esomeprazole magneisum d/r drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
esomeprazole magneisum d/r drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
esomeprazole magneisum d/r drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
esomeprazole magneisum d/r drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
esomeprazole magneisum d/r drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
esomeprazole magneisum d/r drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
esomeprazole magneisum d/r drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
esomeprazole magneisum d/r drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | esomeprazole magneisum d/r | 61919-868 |
| >Company | >Ingredient | >NDC |
esomeprazole magneisum d/r drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links